The Food and
Drugs Authority (FDA) has issued an immediate recall for all shipments of
Beltocin and Vernetocin Injections (Oxytocin 10IU/ML) imported by Hills
Pharmacy and Alpha Duo Pharma Ltd, respectively.
Through their
quality monitoring efforts, the Authority has identified discrepancies in
laboratory analyses for both Beltocin and Vernetocin (Oxytocin) injections at
10IU/ML concentration, with several batches failing to meet the established
quality standards.
In light of
this, the Authority is formally requesting all healthcare facilities, medical
stores, and pharmacies that have any quantities of these medical products in
their inventory to promptly cease their administration and arrange for their
return to the respective suppliers and importers.
Meanwhile, to
enhance effective collaboration between stakeholders in the food and medical
products research space, the Chief Executive of the FDA, Dr Delese A. A. Darko
has called for stronger partnerships between the Authority and industry
players.
Dr Darko made
this call at the maiden edition of the FDA’s Scientific Forum which was held on
Thursday, September 14 in Accra.
Held on the
theme “Protecting Public Health and Safety Through Partnerships”, the forum
brought together the academic community, industry players, sister agencies,
research institutions, as well as current and potential collaborators of the
FDA to share knowledge for the general advancement of food and medical
products’ safety, quality and efficacy in Ghana.
The forum also
had as part of its objectives to encourage discussions on partnering for
success in local vaccine research, development, and production.
“We are in a
fast-paced scientific world and as a key player in the field of science in
Ghana, our work requires close collaboration between the organization and
higher learning institutions and industry players at the forefront of knowledge
in research and development. As a regulator, we must regularly engage with such
bodies to keep at pace with our field. We put this forum together to provide a
platform for active discussions on ensuring the quality and safety of food and
medical products through effective collaboration.
“We will need
even stronger partnerships for us to fulfil our mandate. Our aim is to
strengthen the relationship between us and all the stakeholders whose work
impacts food and medical products, so we learn from each other in order to
improve the work we do for the benefit of the consumer” Dr Darko remarked.
0 comments:
Post a Comment